BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2975225)

  • 21. The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats.
    Nanry KP; Tilson HA
    Psychopharmacology (Berl); 1989; 97(4):507-13. PubMed ID: 2524858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
    Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
    Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of buspirone differ from those of gepirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on unpunished responding of pigeons.
    Barrett JE; Fleck-Kandath C; Mansbach RS
    Pharmacol Biochem Behav; 1988 Jul; 30(3):723-7. PubMed ID: 2905470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 5-HT1A selective anxiolytics on lordosis behavior: interactions with progesterone.
    Mendelson SD; Gorzalka BB
    Eur J Pharmacol; 1986 Dec; 132(2-3):323-6. PubMed ID: 2880737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic modulation of the acoustic startle response in rats during preweaning development.
    Sheets LP; Cook LL; Reiter LW
    Pharmacol Biochem Behav; 1989 Jun; 33(2):415-22. PubMed ID: 2530591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat.
    Svensson L
    Psychopharmacology (Berl); 1985; 85(4):469-75. PubMed ID: 3161114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm.
    Kehne JH; Cassella JV; Davis M
    Psychopharmacology (Berl); 1988; 94(1):8-13. PubMed ID: 2894703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT1A and 5-HT1B agonists play a differential role on the respiratory frequency in rats.
    Edwards E; Whitaker-Azmitia PM; Harkins K
    Neuropsychopharmacology; 1990 Apr; 3(2):129-36. PubMed ID: 2138459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminative stimulus properties of flesinoxan.
    Ybema CE; Slangen JL; Olivier B; Mos J
    Pharmacol Biochem Behav; 1990 Apr; 35(4):781-4. PubMed ID: 2140607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.
    Higgins GA; Jones BJ; Oakley NR
    Psychopharmacology (Berl); 1992; 106(2):261-7. PubMed ID: 1347954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; BolaƱos FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons.
    Witkin JM; Mansbach RS; Barrett JE; Bolger GT; Skolnick P; Weissman B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological effects of selective 5-HT1a and 5-HT1b ligands in rat hippocampus: comparison to 5-HT.
    Segal M; Azmitia EC; Whitaker-Azmitia PM
    Brain Res; 1989 Nov; 502(1):67-74. PubMed ID: 2531014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors.
    Bobker DH; Williams JT
    J Pharmacol Exp Ther; 1989 Jul; 250(1):37-43. PubMed ID: 2526217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.